| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/28/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Employee Stock Option (right to buy) | 181.5k | $18.66 | $3.4M | | 01/28/2021 |
| 01/31/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Employee Stock Option (right to buy) | 165.2k | $13.29 | $2.2M | | 01/31/2020 |
| 06/05/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise | Employee Stock Option (right to buy) | 169.5k | $0.60 | $101.7k | | 06/05/2019 |
| 05/14/2019 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock | 1000 | $10.16 | $10.2k | | 05/14/2019 |
| 05/08/2019 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock | 1000 | $10.56 | $10.6k | | 05/08/2019 |
| 05/03/2019 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock | 1000 | $10.53 | $10.5k | | 05/03/2019 |
| 12/03/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 | 2.8k | $0.30 | $843.2 | | 12/03/2018 |
| 11/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 | 2.9k | $0.31 | $908.3 | | 11/01/2018 |
| 10/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 | 2.9k | $0.45 | $1.3k | | 10/01/2018 |
| 09/04/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 | 2.8k | $0.50 | $1.4k | | 09/04/2018 |
| 08/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 2.8k | $0.47 | $1.3k | | 08/01/2018 |
| 07/02/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 2.8k | $0.50 | $1.4k | | 07/02/2018 |
| 06/13/2018 | Celldex Therapeutics, Inc. | CLDX | Grant | | 67k | $0.60 | $40.3k | | 06/13/2018 |
| 06/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 2.8k | $0.58 | $1.6k | | 06/01/2018 |
| 05/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 2.8k | $0.74 | $2.1k | | 05/01/2018 |
| 04/02/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.4k | $2.33 | $7.9k | | 04/02/2018 |
| 03/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.4k | $2.25 | $7.7k | | 03/01/2018 |
| 02/01/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.4k | $2.76 | $9.4k | | 02/01/2018 |
| 01/02/2018 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.7k | $2.84 | $10.4k | | 01/02/2018 |
| 12/01/2017 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.2k | $3.00 | $9.6k | | 12/01/2017 |
| 11/01/2017 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $0.001 per share | 3.2k | $2.44 | $7.8k | | 11/01/2017 |
| 04/03/2017 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $.001 per share | 2.9k | $3.61 | $10.4k | | 04/03/2017 |
| 03/01/2017 | Celldex Therapeutics, Inc. | CLDX | Payment of Exercise | Common Stock, par value $.001 per share | 32.9k | $3.54 | $116.6k | | 03/01/2017 |
| 12/14/2016 | Celldex Therapeutics, Inc. | CLDX | Grant | | 8k | $3.72 | $29.8k | | 12/14/2016 |
| 06/01/2016 | Oncotelic Therapeutics, Inc. | MATN | Grant | Stock Option (Right to Purchase) | 91.6k | $0.65 | $59.5k | | 06/01/2016 |
| 06/09/2010 | PONIARD PHARMACEUTICALS, INC. | PARD | Grant | Restricted Stock Units | 36.1k | $0.00 | $0 | | 06/09/2010 |
| 06/09/2010 | PONIARD PHARMACEUTICALS, INC. | PARD | Grant | Restricted Stock Units | 72.3k | $0.00 | $0 | | 06/09/2010 |